Itamar Medical Appoints Marga Ortigas-Wedekind to its Board of Directors
August 12 2021 - 6:00AM
Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical
device and digital health company focused on the integration of
sleep apnea management into the cardiac patient care pathway, today
announced the appointment of Marga Ortigas-Wedekind to its Board of
Directors.
Ms. Ortigas-Wedekind brings more than 30 years of medical
technology and digital health experience including leadership roles
in commercial and strategic marketing. She is currently the Chief
Commercial Strategy Officer for Fogarty Innovation, a nonprofit
organization in the medical technology space. In this role she is
responsible for delivering commercial strategy guidance and
defining the digital health strategy. Prior, Ortigas-Wedekind
served as EVP, Marketing and Payer Relations for iRhythm
Technologies, a leading digital health care solutions company
focused on the advancement of cardiac care. Previously she was EVP,
Global Marketing and Product Development at Omnicell Inc. Earlier
in her career, she was SVP, Marketing, Development, and Clinical
Affairs at Xoft, Inc. (now iCAD) and VP, Sales and Marketing at
Pro-Duct Health, Inc. (now Hologic).
“We are pleased to welcome Marga to Itamar’s board,” said Dr.
Giora Yaron, Chairman of Itamar’s Board of Directors. “Her
background and experience in the healthcare and digital health
sectors perfectly align with our long-term goals.”
Ms. Ortigas-Wedekind earned a master’s degree in International
Business and Marketing from the Stanford Graduate School of
Business and a bachelor’s degree in Political Economy from
Wellesley College. She currently serves as an Advisory Committee
Member at Launchpad Digital Health and a Member of HealthTech
Capital.
About Itamar Medical Ltd.Itamar Medical is a
medical technology company focused on the development and
commercialization of non-invasive medical devices and solutions to
aid in the diagnosis of respiratory sleep disorders. Itamar Medical
commercializes a digital healthcare platform to facilitate the
continuum of care for effective sleep apnea management with a focus
on the core sleep, cardiology and direct to consumer markets.
Itamar Medical offers a Total Sleep Solution to help physicians
provide comprehensive sleep apnea management in a variety of
clinical environments to optimize patient care and reduce
healthcare system costs. The Company’s key product, WatchPAT, is
commercially available within major markets including the US,
Japan, and Europe. Itamar Medical is a public company traded on the
Nasdaq and on the Tel Aviv Stock Exchanges, and is based in
Caesarea, Israel with U.S. headquarters based in Atlanta, GA. For
additional information visit www.itamar-medical.com
Itamar Medical Investor Relations Contact
(U.S.)
Leigh Salvo Gilmartin GroupPhone:
+1-510-693-5238investors@itamar-medical.com
Itamar Medical (NASDAQ:ITMR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Itamar Medical (NASDAQ:ITMR)
Historical Stock Chart
From Sep 2023 to Sep 2024